Market cap
$60,022 Mln
Market cap
$60,022 Mln
Revenue (TTM)
$17,438 Mln
P/E Ratio
16.8
P/B Ratio
2
Div. Yield
2 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$3,646 Mln
ROE
0.1 %
ROCE
10.2 %
Industry P/E
--
EV/EBITDA
0
Debt to Equity
0.3
Book Value
$55.4
EPS
$6.9
Face value
--
Shares outstanding
515,183,672
CFO
$54,988.00 Mln
EBITDA
$42,936.00 Mln
Net Profit
$36,918.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aflac Inc (AFL)
| 3.8 | 7.7 | 5.4 | 9.0 | 20.1 | 16.4 | 13.0 |
|
BSE Sensex
| -7.3 | 5.3 | -4.1 | -1.1 | 9.6 | 10.5 | 11.7 |
|
S&P 100
| 1.3 | 10.1 | 3.5 | 37.7 | 23.0 | 13.2 | 14.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Aflac Inc (AFL)
| 6.6 | 25.2 | 14.7 | 23.2 | 34.5 | -13.6 | 18.6 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aflac Inc (AFL)
|
114.4 | 60,021.5 | 17,438.0 | 3,646.0 | 26.6 | 13.1 | 16.8 | 2.0 |
| 219.6 | 56,975.9 | 13,941.8 | 1,493.9 | 18.2 | 6.9 | 39.1 | 2.5 | |
| 67.7 | 22,651.6 | 5,956.0 | 1,054.0 | 28.5 | 11.1 | 21.1 | 1.8 | |
| 17.0 | 45,494.8 | 60,774.0 | 3,576.0 | 7.6 | 11.9 | -- | 0.0 | |
| 26.4 | 12,923.6 | 2,889.0 | -366.0 | 0.4 | -3 | -- | 1.0 | |
| 137.6 | 38,364.3 | 28,258.0 | 3,836.0 | 17.5 | 21.7 | 10.4 | 2.1 | |
| 76.7 | 50,794.0 | 77,084.0 | 3,379.0 | 0.0 | 12.1 | 16.4 | 1.8 | |
| 94.1 | 33,721.2 | 60,774.0 | 3,576.0 | 7.6 | 11.9 | 9.7 | 1.0 | |
| 76.8 | 13,039.7 | 13,054.4 | 738.5 | 8.8 | 6.7 | 18.6 | 1.1 | |
| 290.0 | 28,140.6 | 9,708.0 | 1,605.0 | 23.0 | 20.2 | 18.3 | 3.5 |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT... insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia. Read more
President, Chairman & CEO
Mr. Daniel Paul Amos
Chairman & CEO
Mr. Daniel Paul Amos
Headquarters
Columbus, GA
Website
The share price of Aflac Inc (AFL) is $114.44 (NYSE) as of 22-Apr-2026 11:43 EDT. Aflac Inc (AFL) has given a return of 20.15% in the last 3 years.
The P/E ratio of Aflac Inc (AFL) is 16.79 times as on 17-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.09
|
1.99
|
|
2024
|
10.74
|
2.24
|
|
2023
|
10.36
|
2.19
|
|
2022
|
10.14
|
2.23
|
|
2021
|
8.94
|
1.16
|
The 52-week high and low of Aflac Inc (AFL) are Rs 119.32 and Rs 96.95 as of 22-Apr-2026.
Aflac Inc (AFL) has a market capitalisation of $ 60,022 Mln as on 17-Apr-2026. As per SEBI classification, it is a Large Cap company.
Before investing in Aflac Inc (AFL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.